Protective Effects of High-Density Lipoprotein on Cancer Risk: Focus on Multiple Myeloma

Lipid metabolism is intrinsically linked to tumorigenesis. And one of the most important characteristics of cancer is the modification of lipid metabolism and its correlation with oncogenic signaling pathways within the tumors. Because lipids function as signaling molecules, membrane structures, and...

Full description

Bibliographic Details
Main Authors: Alessandro Allegra, Giuseppe Murdaca, Giuseppe Mirabile, Sebastiano Gangemi
Format: Article
Language:English
Published: MDPI AG 2024-02-01
Series:Biomedicines
Subjects:
Online Access:https://www.mdpi.com/2227-9059/12/3/514
_version_ 1797241975673454592
author Alessandro Allegra
Giuseppe Murdaca
Giuseppe Mirabile
Sebastiano Gangemi
author_facet Alessandro Allegra
Giuseppe Murdaca
Giuseppe Mirabile
Sebastiano Gangemi
author_sort Alessandro Allegra
collection DOAJ
description Lipid metabolism is intrinsically linked to tumorigenesis. And one of the most important characteristics of cancer is the modification of lipid metabolism and its correlation with oncogenic signaling pathways within the tumors. Because lipids function as signaling molecules, membrane structures, and energy sources, lipids are essential to the development of cancer. Above all, the proper immune response of tumor cells depends on the control of lipid metabolism. Changes in metabolism can modify systems that regulate carcinogenesis, such as inflammation, oxidative stress, and angiogenesis. The dependence of various malignancies on lipid metabolism varies. This review delves into the modifications to lipid metabolism that take place in cancer, specifically focusing on multiple myeloma. The review illustrates how changes in different lipid pathways impact the growth, survival, and drug-responsiveness of multiple myeloma cells, in addition to their interactions with other cells within the tumor microenvironment. The phenotype of malignant plasma cells can be affected by lipid vulnerabilities, and these findings offer a new avenue for understanding this process. Additionally, they identify novel druggable pathways that have a major bearing on multiple myeloma care.
first_indexed 2024-04-24T18:31:52Z
format Article
id doaj.art-034b00e2e0094c76857f74f6a2db5db8
institution Directory Open Access Journal
issn 2227-9059
language English
last_indexed 2024-04-24T18:31:52Z
publishDate 2024-02-01
publisher MDPI AG
record_format Article
series Biomedicines
spelling doaj.art-034b00e2e0094c76857f74f6a2db5db82024-03-27T13:22:37ZengMDPI AGBiomedicines2227-90592024-02-0112351410.3390/biomedicines12030514Protective Effects of High-Density Lipoprotein on Cancer Risk: Focus on Multiple MyelomaAlessandro Allegra0Giuseppe Murdaca1Giuseppe Mirabile2Sebastiano Gangemi3Hematology Unit, Department of Human Pathology in Adulthood and Childhood “Gaetano Barresi”, University of Messina, Via Consolare Valeria, 98125 Messina, ItalyDepartment of Internal Medicine, University of Genova, Viale Benedetto XV, 16132 Genova, ItalyHematology Unit, Department of Human Pathology in Adulthood and Childhood “Gaetano Barresi”, University of Messina, Via Consolare Valeria, 98125 Messina, ItalyAllergy and Clinical Immunology Unit, Department of Clinical and Experimental Medicine, University of Messina, Via Consolare Valeria, 98125 Messina, ItalyLipid metabolism is intrinsically linked to tumorigenesis. And one of the most important characteristics of cancer is the modification of lipid metabolism and its correlation with oncogenic signaling pathways within the tumors. Because lipids function as signaling molecules, membrane structures, and energy sources, lipids are essential to the development of cancer. Above all, the proper immune response of tumor cells depends on the control of lipid metabolism. Changes in metabolism can modify systems that regulate carcinogenesis, such as inflammation, oxidative stress, and angiogenesis. The dependence of various malignancies on lipid metabolism varies. This review delves into the modifications to lipid metabolism that take place in cancer, specifically focusing on multiple myeloma. The review illustrates how changes in different lipid pathways impact the growth, survival, and drug-responsiveness of multiple myeloma cells, in addition to their interactions with other cells within the tumor microenvironment. The phenotype of malignant plasma cells can be affected by lipid vulnerabilities, and these findings offer a new avenue for understanding this process. Additionally, they identify novel druggable pathways that have a major bearing on multiple myeloma care.https://www.mdpi.com/2227-9059/12/3/514multiple myelomacancerlipid metabolismlow-density lipoproteinhigh-density lipoproteininflammation
spellingShingle Alessandro Allegra
Giuseppe Murdaca
Giuseppe Mirabile
Sebastiano Gangemi
Protective Effects of High-Density Lipoprotein on Cancer Risk: Focus on Multiple Myeloma
Biomedicines
multiple myeloma
cancer
lipid metabolism
low-density lipoprotein
high-density lipoprotein
inflammation
title Protective Effects of High-Density Lipoprotein on Cancer Risk: Focus on Multiple Myeloma
title_full Protective Effects of High-Density Lipoprotein on Cancer Risk: Focus on Multiple Myeloma
title_fullStr Protective Effects of High-Density Lipoprotein on Cancer Risk: Focus on Multiple Myeloma
title_full_unstemmed Protective Effects of High-Density Lipoprotein on Cancer Risk: Focus on Multiple Myeloma
title_short Protective Effects of High-Density Lipoprotein on Cancer Risk: Focus on Multiple Myeloma
title_sort protective effects of high density lipoprotein on cancer risk focus on multiple myeloma
topic multiple myeloma
cancer
lipid metabolism
low-density lipoprotein
high-density lipoprotein
inflammation
url https://www.mdpi.com/2227-9059/12/3/514
work_keys_str_mv AT alessandroallegra protectiveeffectsofhighdensitylipoproteinoncancerriskfocusonmultiplemyeloma
AT giuseppemurdaca protectiveeffectsofhighdensitylipoproteinoncancerriskfocusonmultiplemyeloma
AT giuseppemirabile protectiveeffectsofhighdensitylipoproteinoncancerriskfocusonmultiplemyeloma
AT sebastianogangemi protectiveeffectsofhighdensitylipoproteinoncancerriskfocusonmultiplemyeloma